InstituteOfScience.com

AUTOHEMOTHERAPY/AUTOSEROTHERAPY SUBJECTS

GO TO REFERENCE LIST

A.M.A. endorsement (for psoriasis) - JAMA 111 (1938), p. 343

antibody fragments (immunologic enhancement); modification of Theurer's autohemotherapy 71G2

anticoagulants - recommend against use of - 38A16-784, 65F1, Unger [LJ, Canad. Pract. & Rev., Oct. 1916 per NYMJ 4 Nov. 1916, 914]

Autoblood: See Autohemotherapy

Auto-hemic therapy 21A2, 21A3, 22E10, 23E1, 25E3, 41C1

Autohemotherapy: 12E4, 15E4, 18E6, 22E3, 23A1, 23E9, 24A4, 24A10/24E8, 24E8, 25A1/25E5, 25E2, 25E4, 25E5, 25E6, 25E7, 25E9, 26A3, 26E3, 26E3, 26E7, 27A1, 29A1, 29B1, 29B2, 29B3, 32A1, 32A2, 34A1, 34B2, 35A1, 36A1, 37A1, 37A5, 37A14, 37A26, 40A2

Autohemotherapy vs. Autoserum: 13E7, 21E5/21A2, 21A3, 23E7 (auto- v.s. hetero-), 25A2, 26E1, 26E6, 34B13

Autohemocrinotherapy - 39B6, 40A5, 40B6, 50C2
--for angiospasm of extremities - 39A4
--for epilepsy - 38A14
--for inflammations - 47A2
--for psychopathies - 32A7
--ovarian in scleroderma - 34A13

Autoinoculation - 11E6, 11E9

Autolactotherapy: 14E5

autologous blood collection, with reference to autohemotherapy, from critically ill patients; quality assurance 93G1

Autolymphotherapy: 24E5

Autopyotherapy (pus): 15E3, 15E5, 17E4; see also AUTOVACCINE SUBJECTS

Autoserotherapy: 05E1, 10E1, 11E2, 11E5, 11E8, 13E5, 13E6, 13E9, 14E6, 16A1, 16E3, 17E1, 18E5, 20A2, 22E8, 23E4, 25A10, 25E1, 25E8, 26E5, 26A10, 27B34, 28A20, 31A2, 31A4
--and autoblood - 13E7
--and blood therapy - 16H7
--and diagnosis - 06E1
--blister serum- 01H1,16H4,13E4,22E4,23E5, 25E11, 35B15, 38B8, 41B5
----cantharidin blister: 25A9
----for measles and grippe: 26E9
----for opium addiction, 1000 addicts: 37A11
----toxicomania: 35B15, 38B8, 41B5
--filtered liquid - 12E6
--"integral" (=autohemotherapy) - 21A1/21E3, 21A4, 21E4, 22A2, 22E9

Autotherapy: 11E10, 12E1, 13E4, 14E3 (urine and sea plasma), 15E1, 15E8, 16E1, 17E2, 18E3 (and homeopathy), 19E1, 22E5, 24E6

Autotransfusion: 26B7

GO TO REFERENCE LIST

Blood, effects/influence of autohemotherapy on [see also autovaccine, topics]: 26B10, 27B9, 31B4, 35B16, 51C2
--amino acid curve 36A13
----in gonorrhea - 38B10
--antibodies - 55B1
--blood cholesterol, pulmonary TB - 40B2
--blood dextrose - 38A11
--blood groups, related to - 47A4
--calcemia - 35B3
--carotid sinus cardiovascular reflex - 37A13
--change due to exteriorization - 14H3, 38A6
--chlorides in blood and urine - 35B3
--coagulation and bleeding time shortened - 50A2
--corpuscles - 27B8
--distases in blood and urine - 35B4
--erythrocyte(s)
---granulofilamentous substance - 36B6
---role in upkeep of cellular tissues - 47B3
---sedimentation - 36B11
----- in children - 31B13
----- in pulmonary tuberculosis patients - 40B2
--erythropoiesis, fresh and hemolyzed autoblood - 39B5
--immunobiologic activity of blood - 42A1
--in cancer of uterus - 29B19
--leukocytes - 13E11
---in trachoma - 35A16
---with hemolyzed autoblood - 38A16
--medium-molecular peptides - 86F1 [86G2] [UV autohemo]
--nitrogen fractions - 35B1
--plasmatic and globular cholesteremia - 35B2
--protein content - 31B13 in children
--reticulocyte content - 30B8

Bloodletting - see Venesection

GO TO REFERENCE LIST

Combinations of therapy types: Autohemo[sero]therapy with -
-- antibiotics - 53C1
---in dentistry - 52C3
---in dermatology [autosero-] - 54D5
--artificial fever - 40B1 in rheumatic disease
--bacterine - 16E2, 16H6
--endocrine therapy - see "autohemocrinotherapy"
--histaminic - 50C2
--iontophoresis (medicament ions intro. by elect. current) - 27A3
--irradiation - see irradiated autoblood
--malaria/hyperpyrexia - 38A16
--penicillin
---for abscess - 56D2d
---for furuncles and carbuncles - 59D2
---for phlebitis - 48A1, 48A2
---for pyoderma - 54D5
--prothrombin - 54C1 (hand ganglion)
--rivanol - 26A8
--serum - 51A1 [anti-serum], 44A4 [convalescent serum]
--testicular extract - 31A5 (Dupytren's disease, plantar fibromatosis of foot)
--vaccine therapy and/or autosensitized vaccines - 15E2, 16E2, 16H1, 16H6, 18E2, 18E4, 22E1, 33B8; see also AUTOVACCINE SUBJECTS
--venesection - 17A1
--whale oil and tricophytin - 49A3 (epidermophytosis)

Cupping:
--as autohemotherapy - 25E12
--effect of cupping/autohemotherapy on blood reticulocyte content - 30B8

GO TO REFERENCE LIST

Dangers of --
--autohemotherapy:
---vagaries - 24E10
---without exam. - 31A6
--autoserotherapy: 21E1
---hemoclasis - 22A2
---Gilbert's method - 25A12
---traumatic muscular tuberculosis following - 48B3

GO TO REFERENCE LIST

Effects of autohemotherapy:
--on adrenal cortex - 51C7
--on blood; see Blood, effects...
--on distases in urine - 35B4
--euphoria after - 26E8, 26B9
--on immunity (autoprotein) - 30B9
--on internal organs (parenetal admin. of autoprotein) - 30B19
--paradoxic reaction, laked, incubated autoblood - 56B1
--pressor effects, according to hour of admin. - 36B10
--on tissues - 33B9

Experiments, autohemotherapy:
--Dr. Caride's - 27B11
--effect of spleen on IM absorption time - 50A1
--for dichloroethyl sulfide intox. in dogs - 38A2

Exteriorization of blood, effect - 14H3, 38A6

GO TO REFERENCE LIST

Failure, complications of autohemotherapy:
--clinical reactions - 24E1
---in herpes zoster - 31A10
---in purpura - 24E3
--negative results
---in cases of fixed serologic reactions - 41B1
---for post-operative embolism - 37B15

GO TO REFERENCE LIST

Hemolyzed autoblood, use of: 23E3, 23A8/24E4, 23A9, 30A2
--in aqueous solution - 56D1, 38A1
--for deep-seated phlegmons (4 cases) - 33A19
--for hypertension - 54D1
--in surgery - 23E2, 24E7, 38A16 [IV], 39B5
--in gynecology [parenterale Eiwesstherapie] - 24E9
--in mental illness - 38A1 [hemolyzed blood in distilled water]

GO TO REFERENCE LIST

Indications for autohemotherapy: 31B11, 40A8, 40B7, 41B4, 35A9

Instruments for autohemotherapy: 25A15

Irradiated autoblood (ultraviolet rays): 25E10, 38B13, 40A6, 51C4
--effect on blood, etc.:
---desensitizing action [autoserum] - 37A15
---immunobiologic - 42A1
--Havlicek method - 38A13
--in gynecology - 38B14, 40B8
--in herpes recurrens of hands - 28A1
--in obstetrics - 40B8
--intravenous - 55D2, 53A1 IV/IM results
--irradiation not necessary - 49H1
--using Kromayer lamp - 41A9
see also anemia

GO TO REFERENCE LIST

Malaria therapy - 32H1
--combined with autohemotherapy - 38A16

Mechanism/mode of action of autohemotherapy (hypotheses): 27B32, 31B13, 33A11, 34A12, 48C1
--and application - 27B31
--as protein therapy
---24A9 [hemolyzed]
---27A2 (v.s. anti-anaphylactic therapy)
---29A2 (in aseptic shock in nephritis)
--as non-specific irritant - 23A8 [hemolyzed]
--auto-antibody form, induced by autohemo- - 56C1
--autoserotherapy - 13E1, 16A2, 16A3, 16E4
--hypositive action of - 40A7
--research - 24E11
--with antibody fragments (immunologic enhancement) - 72F3

Method/Technic [Autohemotherapy-I.M. or as specified]: 28A22, 34A11
--antibody fragments, treatment with - 72F3
--"antiseptic autohemotherapy" - 44A2
--autoserotherapy - 15E6, 49A2
--Botelho, de Oliveiera, method - 36B5
--Gilbert's method [autosero-]: 12E9, 13E3, 14E1
---danger - 25A12
--intracutaneous - 25A16; see intradermal
---favorable and unfavorable results - 31B12
--intradermal - 49D1
---hemolysis - 32B1
--intraspinal - 25A17
---in epidemic encephalitis - 26B11
---in poliomyelitic tetraplegia - 32A12 [autosero-]
--intravenous, 26B7,38A19
---hemolyzed - 38A16
---irradiated - 55D2, 53A1 (or IM)
---v.s. X-rays - 25A11
--subcutaneous - 15E3 (pneumonia)

GO TO REFERENCE LIST

ozone, biological effects - induction of tumor necrosis factor (TNF-alpha) on human leukocytes 91G1

ozone, biological effects - an attempt to define conditions for optimal induction of cytokines 93G2

GO TO REFERENCE LIST

Prophylaxis, autohemotherapy as - 24E8

Pyrotherapy - 32H1

Pus - see Autopyotherapy

GO TO REFERENCE LIST

quantum ultraviolet autohemotherapy, method and the clinical effect of 89G1

GO TO REFERENCE LIST

Research:
--autohemotherapy - 24E11
--autoserotherapy
---clinical - 21E2
---experimental - 12E5, 12E8

Review/survey of autohemotherapy: 25A26 (208 cases), 26A11, 27A12 (various diseases), 29B16 (survey), 30B15 (55 cases)

GO TO REFERENCE LIST

Safety of:
--autohemotherapy, IM - 39A3, 55C2, 57C3, 32H1, 37B3, 38A6, 49B1
--autoserotherapy of Gilbert (S.C. of non-purulent fluid of pleural effusion): 15H1, 11E2, 16A1, 11E1,
--autoserum (defibrinated autoblood) 14H2 (IM or IV), 14H3 (IV), 17H1 (IM "safer"), 21A1 (heated), 17A1, 37B25 (Irradiated, IM), 32H1

Sea Plasma, use of: 14E3 [autotherapy]

GO TO REFERENCE LIST

Urine, use of: 14E3 [autotherapy]

Uses/applications of autohemotherapy: 27B31, 27B33, 28B3
--as therapeutic agent: 35A9
--as vehicle for medicaments, 37A2, 52C2
--clinical and therapeutic study: 30A1
--in homeopathy: 52C2

GO TO REFERENCE LIST

Venesection
--autoserotherapy as - 14H2, 14H3
--and autohemotherapy - 17A1
--explanation of action, as vaccinetherapy - 17A1
--explanation of action, as autohemotherapy - 38B2